Skip to main content
. 2022 May 4;20:143. doi: 10.1186/s12957-022-02607-0

Table 2.

Univariate analysis in regard to overall survival according to clinicopathological features for 56 patients with EASC

Variable No. of patients 1-year OS (%) 3-year OS (%) 5-year OS (%) P value
Sex 0.282
 Male 43 71.8 42.3 21.9
 Female 13 84.6 59.2 29.2
Age (year) 0.271
 ≤ 60 27 77.6 49.7 36.1
 > 60 29 71.8 42.8 22.8
Tumor location 0.918
 Upper third 9 100.0 62.5 31.3
 Middle third 37 70.3 45.4 30.3
 Lower third 10 70.0 35.0 -
Tumor length 0.036
 ≤ 4 cm 26 84.6 56.1 41.6
 > 4 cm 30 65.5 36.4 18.2
Thoracotomy 0.102
 Left thoracotomy 37 67.6 35.1 26.4
 Right thoracotomy 19 88.2 70.1 31.5
Resection margin 0.091
 Radical 49 79.2 48.6 32.0
 Palliative 7 42.9 28.6 14.3
pT category 0.434
 pT1-T2 9 87.5 54.7 18.2
 pT3-T4 47 72.2 43.7 30.7
pN category 0.082
 pN0 24 83.3 54.2 39.4
 pN1-N3 32 67.7 40.1 21.4
Adjuvant radiotherapy 0.667
 Yes 14 78.6 50.0 28.6
 No 42 73.2 44.8 30.6
Adjuvant chemotherapy 0.153
 Yes 8 87.5 87.5 58.3
 No 48 72.3 38.9 25.0

OS overall survival